Terumo Interventional Systems announces the launch and commercial availability of its NaviCross peripheral support catheter in the USA, further expanding the company’s radial-to-peripheral (R2P) portfolio.
The R2P NaviCross catheter is now available in a 200cm length and is a double-braided, stainless-steel construction engineered for trackability and torque control for lesion crossing in complex procedures, a press release states.
“Our customers have been asking for a longer length, high-performance NaviCross support catheter, and I am proud to say we answered the need by delivering R2P NaviCross to the market, further enhancing our radial-to-peripheral portfolio,” said Ghada Farah, division president, Terumo Interventional Systems. “R2P NaviCross solidifies Terumo’s leadership in radial access, particularly as the demand for procedures to treat peripheral artery disease (PAD) and critical limb ischaemia continues to rise.”
“With the 200cm length, the R2P NaviCross catheter provides physicians performing percutaneous transluminal endovascular procedures from the radial artery a valuable tool to enhance their ability to safely and efficiently complete more procedures from a radial approach,” said Michael J Martinelli, chief medical officer, Terumo Medical Corporation. “Additionally, the double-braided, stainless-steel design of the R2P NaviCross catheter makes it possible to access and cross simple-to-complex lesions above and below the knee.”
